Schrag L, Liu X, Thevarajan I, Prakash O, Zolkiewski M, Chen J. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain. J Mol Biol. 2021;433:167048 pubmed publisher

Dowarha D, Chou R, Yu C. S100A1 blocks the interaction between p53 and mdm2 and decreases cell proliferation activity. PLoS ONE. 2020;15:e0234152 pubmed publisher

Morimoto J, Hosono Y, Sando S. Isolation of a peptide containing d-amino acid residues that inhibits the α-helix-mediated p53-MDM2 interaction from a one-bead one-compound library. Bioorg Med Chem Lett. 2018;28:231-234 pubmed publisher

Borcherds W, Theillet F, Katzer A, Finzel A, Mishall K, Powell A, et al. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. Nat Chem Biol. 2014;10:1000-2 pubmed publisher